Ferrero JM - Search Results

1

Weekly paclitaxel, capecitabine, and bevacizumab with maintenance capecitabine and bevacizumab as first-line therapy for triple-negative, metastatic, or locally advanced breast cancer: Results from the GINECO A-TaXel phase 2 study.

Ferrero JM, Hardy-Bessard AC, Capitain O, Lortholary A, Salles B, Follana P, Herve R, Deblock M, Dauba J, Atlassi M, Largillier R. Ferrero JM, et al. Cancer. 2016 Oct 15;122(20):3119-3126. doi: 10.1002/cncr.30170. Epub 2016 Jul 14. Cancer. 2016. PMID: 27412268 Free article. Clinical Trial.

2

Palliative 5-fluorouracil-based chemotherapy for advanced colorectal cancer in the elderly: results of a 10-year experience.

Magné N, François E, Broisin L, Guardiola E, Ramaïoli A, Ferrero JM, Namer M. Magné N, et al. Among authors: ferrero jm. Am J Clin Oncol. 2002 Apr;25(2):126-30. doi: 10.1097/00000421-200204000-00005. Am J Clin Oncol. 2002. PMID: 11943888

3

The raltitrexed-vinorelbine combination: a phase I pharmacokinetic and pharmacodynamic trial in advanced breast cancer.

Ferrero JM, Chamorey E, Magné N, Leccia F, Largillier R, Namer M, Milano G. Ferrero JM, et al. Cancer Chemother Pharmacol. 2002 Dec;50(6):459-64. doi: 10.1007/s00280-002-0519-2. Epub 2002 Sep 19. Cancer Chemother Pharmacol. 2002. PMID: 12451472 Clinical Trial.

4

[Cardiac tolerance of the combination paclitaxel-anthracyclines in the context of the management of cancer of the breast].

Ferrero JM, Magné N, Foa C, Largillier R, Namer M. Ferrero JM, et al. Bull Cancer. 2003 Mar;90(3):219-26. Bull Cancer. 2003. PMID: 12801824 Free article. Review. French.

5

[Docetaxel and prostate cancer].

Ferrero JM. Ferrero JM. Bull Cancer. 2004 Feb;91(2):172-7. Bull Cancer. 2004. PMID: 15047457 Review. French.

6

Long-term results of adjuvant hypofractionated radiotherapy for breast cancer in elderly patients.

Ortholan C, Hannoun-Lévi JM, Ferrero JM, Largillier R, Courdi A. Ortholan C, et al. Among authors: ferrero jm. Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):154-62. doi: 10.1016/j.ijrobp.2004.04.059. Int J Radiat Oncol Biol Phys. 2005. PMID: 15629606

7

[Hormonoresistant metastatic prostate cancer: analysis of two phase III clinical studies].

Ferrero JM. Ferrero JM. Bull Cancer. 2005 May 1;92(5):425-7. Bull Cancer. 2005. PMID: 15932803 Free article. Review. French.

8

Long-term results of hypofractionated radiotherapy and hormonal therapy without surgery for breast cancer in elderly patients.

Courdi A, Ortholan C, Hannoun-Lévi JM, Ferrero JM, Largillier R, Balu-Maestro C, Chapellier C, Ettore F, Birtwisle-Peyrottes I. Courdi A, et al. Among authors: ferrero jm. Radiother Oncol. 2006 May;79(2):156-61. doi: 10.1016/j.radonc.2006.04.005. Epub 2006 May 15. Radiother Oncol. 2006. PMID: 16698099

9

Phase II trial evaluating a docetaxel-capecitabine combination as treatment for hormone-refractory prostate cancer.

Ferrero JM, Chamorey E, Oudard S, Dides S, Lesbats G, Cavaglione G, Nouyrigat P, Foa C, Kaphan R. Ferrero JM, et al. Cancer. 2006 Aug 15;107(4):738-45. doi: 10.1002/cncr.22070. Cancer. 2006. PMID: 16826591 Free article. Clinical Trial.

10

Synergistic cytotoxic interaction in hormone-refractory prostate cancer with the triple combination docetaxel-erlotinib and 5-fluoro-5'-deoxyuridine.

Fischel JL, Ciccolini J, Formento P, Ferrero JM, Milano G. Fischel JL, et al. Among authors: ferrero jm. Anticancer Drugs. 2006 Aug;17(7):807-13. doi: 10.1097/01.cad.0000224444.23953.90. Anticancer Drugs. 2006. PMID: 16926630

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

282 results

Search Page